Patents by Inventor Cecile Neyt

Cecile Neyt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic composition
    Publication number: 20110008385
    Abstract: The present application relates to immunogenic compositions comprising staphylococcal PNAG and Type 5 and/or 8 capular polysaccharide or oligosaccharide from S. aureus. Vaccines, methods of treatment using and processes to make an immunogenic composition comprising PNAG and Type 5 and/or 8 capsular polysaccharides are also described.
    Type: Application
    Filed: April 15, 2010
    Publication date: January 13, 2011
    Applicant: GlaxoSmithKline Biologicals s.a.
    Inventors: Cindy Castado, Nicolas Pierre Fernand Lecrenier, Cecile A. Neyt, Jan Poolman
  • Immunogenic Composition for Use in Vaccination Against Staphylococcei
    Publication number: 20080095777
    Abstract: The present application relates to immunogenic compositions comprising a mixture of staphylococcal antigens which combines antigen having different functions, for instance, combinations including a staphylococcal extracellular component binding protein and a staphylococcal transporter protein or a staphylococcal extracellular component binding protein and a staphylococcal regulator of virulence or toxin or a staphylococcal transporter protein and a staphylococcal regulator of virulence or toxin. Vaccines, methods of treatment, uses of and processes to make a staphylococcal vaccine are also described.
    Type: Application
    Filed: September 20, 2005
    Publication date: April 24, 2008
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Cindy Castado, Nicolas Lecrenier, Cecile Neyt, Jan Poolman
  • Immunogenic Composition
    Publication number: 20080085289
    Abstract: The present application relates to immunogenic compositions comprising a mixture of staphylococcal antigens which combines antigen having different functions, for instance, combinations including a staphylococcal extracellular component binding protein and a staphylococcal transporter protein or a staphylococcal extracellular component binding protein and a staphylococcal regulator of virulence or toxin or a staphylococcal transporter protein and a staphylococcal regulator of virulence or toxin. Vaccines, methods of treatment, uses of and processes to make a staphylococcal vaccine are also described.
    Type: Application
    Filed: September 20, 2005
    Publication date: April 10, 2008
    Inventors: Cindy Castado, Nicolas Lecrenier, Cecile Neyt, Jan Poolman
  • Vaccine composition
    Publication number: 20060204520
    Abstract: The present invention relates to the field of novel, engineered Gram-negative bacterial strains that have improved outer-membrane vesicle shedding properties, and vaccine compositions comprising these bacteria or vesicles. The present invention provides a hyperblebbing Gram-negative bacterium which has been genetically modified by either or both processes selected from a group consisting of: down-regulation of expression of one or more tol genes; and mutation of one or more gene(s) encoding a protein comprising a peptidoglycan-associated site to attenuate the peptidoglycan-binding activity of the protein(s).
    Type: Application
    Filed: May 15, 2006
    Publication date: September 14, 2006
    Inventors: Francois-Xavier Berthet, Philippe Denoel, Cecile Neyt, Jan Poolman, Joelle Thonnard